Organism name | Lycium chinense |
---|---|
Genus | Lycium |
Family | Solanaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Lycium chinense |
---|---|
Linked NCBI taxonomy ID | 112883 |
Linked level | species |
Family in NCBI taxonomy | Solanaceae |
---|---|
ID | 4070 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Lycium chinense Mill. | ACE Inhibitor |
Lycium chinense Mill. | Analgesic |
Lycium chinense Mill. | Antiaging |
Lycium chinense Mill. | Antibacterial |
Lycium chinense Mill. | Antipyretic |
Lycium chinense Mill. | Bitter |
Lycium chinense Mill. | Depurative |
Lycium chinense Mill. | Hemostat |
Lycium chinense Mill. | Hepatoprotective |
Lycium chinense Mill. | Hepatotonic |
Lycium chinense Mill. | Hypoglycemic |
Lycium chinense Mill. | Hypotensive |
Lycium chinense Mill. | Immunosuppressive |
Lycium chinense Mill. | Mydriatic |
Lycium chinense Mill. | Nephrotonic |
Lycium chinense Mill. | Radioprotective |
Lycium chinense Mill. | Tonic |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00036313
![]() |
(+)-Lyoniresinol 3alpha-O-beta-glucopyranoside
/ (+)-Lyoniresinol 3alpha-O-beta-D-glucopyranoside |
CHEMBL464198
CHEMBL1159486 CHEMBL1159487 CHEMBL1813178 CHEMBL1813179 CHEMBL1813180 CHEMBL1813181 CHEMBL2332109 |
6 / 11 / 5 | No. 174 | No. 22 |
![]() |
||
C00036866
![]() |
Calystegine B4
|
CHEMBL526330
CHEMBL513797 CHEMBL1213469 CHEMBL1984376 |
1 / 6 / 4 | No. 643 | No. 1 |
![]() |
||
C00036868
![]() |
Calystegine C1
/ (+)-Calystegine C1 |
CHEMBL1972699
|
No. 643 | No. 1 |
![]() |
|||
C00028001
![]() |
Calystegine B1
|
CHEMBL1965915
|
C110567
|
No. 643 | No. 1 |
![]() |
||
C00036867
![]() |
Calystegine B5
/ (+)-Calystegine B5 |
No. 643 | No. 1 |
![]() |
||||
C00036870
![]() |
Calystegine N1
|
No. 643 | No. 1 |
![]() |
||||
C00035552
![]() |
Calystegine B3
/ (+)-Calystegine B3 |
CHEMBL526330
CHEMBL513797 CHEMBL1213469 CHEMBL1984376 |
1 / 6 / 4 | No. 643 | No. 1 |
![]() |
||
C00037556
![]() |
N-Methyl-calystegine B2
|
CHEMBL447814
|
No. 643 | No. 1 |
![]() |
|||
C00036865
![]() |
Calystegine A7
|
No. 643 | No. 1 |
![]() |
||||
C00036863
![]() |
Calystegine A5
|
No. 643 | No. 1 |
![]() |
||||
C00036864
![]() |
Calystegine A6
|
No. 643 | No. 1 |
![]() |
||||
C00036613
![]() |
6-Deoxy-fagomine
/ (-)-6-Deoxy-fagomine |
No. 786 | No. 1 |
![]() |
||||
C00002038
![]() |
Fagomine
|
CHEMBL303545
CHEMBL108084 CHEMBL456583 CHEMBL505237 CHEMBL1818435 CHEMBL1818436 CHEMBL1818437 CHEMBL1818438 CHEMBL1818439 |
C105643
|
5 / 9 / 7 | No. 786 | No. 1 |
![]() |
|
C00007205
![]() |
(+)-Lyoniresinol
|
CHEMBL455365
CHEMBL1760594 CHEMBL1761710 |
No. 4145 |
![]() |
||||
C00012761
![]() |
1,2-Dehydro-alpha-cyperone
/ (+)-Eudesma-1,4,11-trien-3-one / (4aS-cis)-5,6,7,8-Tetrahydro-1,4a-dimethyl-7-(1-methylethenyl)-2(4aH)-naphthalenone |
No. 4452 |
![]() |
|||||
C00028498
![]() |
Lyciumin A
|
No. 4771 |
![]() |
|||||
C00028433
![]() |
Kukoamine A
|
CHEMBL79129
|
No. 8476 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P04062 | Glucosylceramidase | Enzyme | C00002038 C00035552 C00036866 | 6 / 4 |
P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002038 | 1 / 2 |
Q14697 | Neutral alpha-glucosidase AB | Enzyme | C00002038 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002038 | 1 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00036313 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00036313 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00036313 | 7 / 3 |
Q9P0U3 | Sentrin-specific protease 1 | Enzyme | C00036313 | 0 / 0 |
P00734 | Prothrombin | S1A | C00036313 | 4 / 2 |
Q9HCG7 | Non-lysosomal glucosylceramidase | Enzyme | C00002038 | 1 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00036313 | 0 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#230000 | Fucosidosis |
P04066
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#232300 | Glycogen storage disease ii |
P10253
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#614409 | Spastic paraplegia 46, autosomal recessive; spg46 |
Q9HCG7
|
#601367 | Stroke, ischemic |
P00734
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00141 | Fucosidosis |
P04066
(related)
|
H00422 | Glycoproteinoses |
P04066
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|